Your browser doesn't support javascript.
loading
On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex.
Köser, Claudio U; Georghiou, Sophia B; Schön, Thomas; Salfinger, Max.
Affiliation
  • Köser CU; Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Georghiou SB; FIND, Geneva, Switzerland.
  • Schön T; Department of Infectious Diseases, Kalmar County Hospital, Linköping University, Kalmar, Sweden.
  • Salfinger M; Unit of Infection and Inflammation, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
J Clin Microbiol ; 59(4)2021 03 19.
Article in En | MEDLINE | ID: mdl-33568463
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / Mycobacterium tuberculosis Type of study: Guideline Limits: Humans Language: En Journal: J Clin Microbiol Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / Mycobacterium tuberculosis Type of study: Guideline Limits: Humans Language: En Journal: J Clin Microbiol Year: 2021 Type: Article Affiliation country: United kingdom